Overview

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

To investigate the efficacy and the safety of ropinirole PR/XR tablets to ropinirole immediate release (IR) tablets with advanced Parkinson's disease in conjunction with L-dopa in a double-blind, parallel group comparison study.

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Levodopa
Ropinirole